Rifaximin, Microbiota Biology and Hepatic Encephalopathy

The effect of sub-inhibitory concentrations of rifaximin on urease production and on other virulence factors expressed by Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa and Staphylococcus aureus

(2016) Annalisa Ricci et al.   JOURNAL OF CHEMOTHERAPY

Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities

(2016) Roger F. Butterworth   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition

(2016) Dae J Kang et al.   Clinical and Translational Gastroenterology

Effects of Rifaximin on Transit, Permeability, Fecal Microbiome and Organic Acid Excretion in Irritable Bowel Syndrome

(2016) Andrés Acosta et al.   Clinical and Translational Gastroenterology

Therapeutic Effects and Mechanisms of Action of Rifaximin in Gastrointestinal Diseases

(2015) Herbert L. DuPont   MAYO CLINIC PROCEEDINGS

Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis

(2014) Joshua Terc et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Altered profile of human gut microbiome is associated with cirrhosis and its complications

(2013) Jasmohan S. Bajaj et al.   JOURNAL OF HEPATOLOGY

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

(2013) Jasmohan S. Bajaj et al.   PLoS One

Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome

(2012) Michael Camilleri et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

A High-Fat Diet Is Associated With Endotoxemia That Originates From the Gut

(2012) Swaroop Pendyala et al.   GASTROENTEROLOGY

Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells

(2011) Andrea Mencarelli et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Bile Acids Improve the Antimicrobial Effect of Rifaximin

(2010) C. Darkoh et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system

(2010) Simone Maccaferri et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY